Skip to main content

Table 1 Abeta accumulation was not modified in the lithium treated PS1xAPP mice

From: In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer’s disease pathology

   Control Lithium
Soluble Abeta42 ELISA 27.57 ± 10.74 30.14 ± 6.47
(pg/ml)   n = 7 n = 7
Total Abeta Western blots 1.0 ± 0.26 0.98 ± 0.60
(relative units) 6E10 n = 18 n = 25
Abeta load Immunohistochemistry 6.83 ± 1.99 4.40 ± 1.81
(% of area) 6E10 n = 5 n = 5
Abeta42 load Immunohistochemistry 5.09 ± 2.31 3.65 ± 1.03
(% of area) Abeta42 n = 5 n = 5
  1. Data are mean ± S.D.